Omnicell, Inc. Overview
Pro stress-test →Omnicell provides medication management solutions and adherence tools for healthcare systems and pharmacies through point of care automation solutions, XT Series automated dispensing systems, and specialized automated dispensing systems for hospitals and health systems. The company is in a critical inflection point with its launch of Omnicell Titan XT, a transformational enterprise version of automated dispensing systems designed to unify proven automation and powerful intelligence.
Strategic Profile
Pro stress-test →Titan XT is intended to address a significant need for an enhanced and more efficient medication management experience that combines proven automation with powerful intelligence and extends beyond the pharmacy into nursing care areas. The company is shifting toward a platform-driven model anchored by OmniSphere with recurring revenue, positioning itself for multi-year growth. The Titan XT refresh cycle opportunity is expected to exceed $2.5 billion and drive a multi-year period of product adoption, revenue expansion, and competitive wins.
Competitive Landscape
Pro stress-test →Omnicell operates in pharmacy automation and medication management with primary competitors in hospital automation space. The company's shift toward a cloud-based platform model (OmniSphere) and enterprise hardware (Titan XT) differentiates it from point-solution competitors and legacy automation providers. Key competitive advantages include integrated point-of-care devices, expanding software services, and established healthcare customer relationships, though it faces competition from both specialized automation vendors and larger health IT companies.
Industry Context
Omnicell, Inc. operates in Healthcare Technology - Pharmacy & Medication Management Automation.
Key facts
Founded: 1992 · Headquarters: Fort Worth, US · Revenue: $1.185B (2025)